NCT04958356View on ClinicalTrials.gov

Newborn Screening for Genetic Susceptibility to Type 1 Diabetes and Celiac Disease and Prospective Follow-up Study

Active, not recruitingOBSERVATIONAL

Enrollment

9,690

Participants

Timeline

Start Date

November 19, 2018

Primary Completion Date

December 31, 2031

Study Completion Date

December 31, 2032

Conditions

Type1diabetesCeliac Disease

Trial Locations (1)

00029

Hospital District of Helsinki and Uusimaa, Helsinki

All Listed Sponsors

lead

University of Helsinki

OTHER